Related Articles
Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI
Histone deacetylase inhibitors alter the expression of molecular markers in breast cancer cells via microRNAs
Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib
Adenovirus-mediated ING4/IL-24 double tumor suppressor gene co-transfer enhances antitumor activity in human breast cancer cells
Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells